Matthew Wein - Mar 5, 2025 Form 4 Insider Report for Metagenomi, Inc. (MGX)

Role
Title: Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Signature
/s/ Matthew L. Wein
Stock symbol
MGX
Transactions as of
Mar 5, 2025
Transactions value $
-$1,744
Form type
4
Date filed
3/7/2025, 04:38 PM
Previous filing
Apr 3, 2024
Next filing
Apr 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGX Common Stock Sale -$1.74K -930 -8.94% $1.87 9.47K Mar 5, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.85 to $1.90, inclusive. The reporting person undertakes to provide to Metagenomi, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Remarks:

Title: Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary